Related Experiment Video
Updated: Dec 21, 2025

07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
14.8K
How Technology Is Improving the Multidisciplinary Care of Sarcoma
Inga-Marie Schaefer1, Kelvin Hong2, Anusha Kalbasi3
1Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA.
Summary
Technological advancements are revolutionizing sarcoma diagnosis and treatment. New biomarkers and advanced radiation techniques are refining classification and improving patient care for these rare tumors.
Area of Science:
- Oncology
- Pathology
- Radiotherapy
Background:
- Sarcomas represent a rare but histologically diverse group of tumors.
- Historically, diagnosis relied on morphology, but technological progress has transformed this.
- Treatment and diagnosis present significant challenges due to biologic complexity.
Purpose of the Study:
- To review recent technological advancements in sarcoma diagnosis and treatment.
- To highlight how new biomarkers refine sarcoma classification and diagnostic approaches.
- To discuss innovations in radiation oncology for sarcoma management.
Main Methods:
- Review of recent literature on diagnostic and therapeutic advances in sarcomas.
- Focus on immunohistochemistry, cytogenetic/molecular testing, and advanced radiotherapy techniques.
- Illustrative examples of specific sarcoma types and their diagnostic refinement.
Main Results:
- Technological advances, including molecular testing, have significantly changed sarcoma diagnostics.
- New biomarkers refine classification and aid in diagnosing specific entities like MPNSTs and round cell sarcomas.
- Advanced radiation techniques (IMRT, SBRT, MRI-guided, proton RT) are crucial for localized and oligometastatic disease.
Conclusions:
- Recent innovations in pathology and radiation oncology are reshaping sarcoma care.
- Biomarkers and advanced diagnostics are crucial for accurate classification and personalized treatment.
- Continued translational research promises further evolution in sarcoma diagnostics and therapy.
Related Concept Videos
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K

